(Q34931955)

5 August 2017

1 reference

title

Anti-inflammatory lipid mediators and insights into the resolution of inflammation (English)

1 reference

5 August 2017

0 references

Derek W Gilroy

3

0 references

author name string

Toby Lawrence

series ordinal

1

1 reference

5 August 2017

Derek A Willoughby

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Nature Reviews Immunology

5 August 2017

published in

1 reference

5 August 2017

volume

2

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

787-795

1 reference

The radiographic resolution of Streptococcus pneumoniae pneumonia

5 August 2017

cites work

1 reference

Time course of symptom resolution in patients with community-acquired pneumonia

31 March 2020

1 reference

Mediators of Inflammation

31 March 2020

1 reference

The role of cytokines and adhesion molecules in the development of inflammatory injury

31 March 2020

1 reference

Local Treatment of Experimental Burns with a Monoamine Oxidase Inhibitor

31 March 2020

1 reference

Venular and capillary permeability in thermal injury

31 March 2020

1 reference

Suppression of Increased Capillary Permeability in Injury by Monoamine Oxidase Inhibitors

31 March 2020

1 reference

Cyclic AMP-elevating agents down-regulate the oxidative burst induced by granulocyte-macrophage colony-stimulating factor (GM-CSF) in adherent neutrophils

31 March 2020

1 reference

The role of cAMP regulation in controlling inflammation

31 March 2020

1 reference

Molecular mechanisms of glucocorticosteroid actions.

31 March 2020

1 reference

Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone

31 March 2020

1 reference

Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro

31 March 2020

1 reference

Lipoxin biosynthesis and its impact in inflammatory and vascular events

31 March 2020

1 reference

Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine

31 March 2020

1 reference

Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity.

31 March 2020

1 reference

Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers

31 March 2020

1 reference

Lipoxins inhibit microvascular inflammatory actions of leukotriene B4

31 March 2020

1 reference

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction

31 March 2020

1 reference

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

31 March 2020

1 reference

Inducible cyclooxygenase may have anti-inflammatory properties

31 March 2020

1 reference

Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia

31 March 2020

1 reference

Role of cyclopentenone prostaglandins in rat carrageenin pleurisy

31 March 2020

1 reference

Lipid mediator class switching during acute inflammation: signals in resolution.

31 March 2020

1 reference

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

31 March 2020

1 reference

Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis

31 March 2020

1 reference

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses

31 March 2020

1 reference

Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists

31 March 2020

1 reference

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

31 March 2020

1 reference

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

31 March 2020

1 reference

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

31 March 2020

1 reference

Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.

31 March 2020

1 reference

Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation

31 March 2020

1 reference

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

31 March 2020

1 reference

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

31 March 2020

1 reference

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

31 March 2020

1 reference

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

31 March 2020

1 reference

Granulocyte apoptosis and its role in the resolution and control of lung inflammation

31 March 2020

1 reference

Corpse clearance defines the meaning of cell death

31 March 2020

1 reference

Possible new role for NF-kappaB in the resolution of inflammation.

31 March 2020

1 reference

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

31 March 2020

1 reference

The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes

31 March 2020

1 reference

Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism

31 March 2020

1 reference

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

31 March 2020

1 reference

Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation

31 March 2020

1 reference

Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation

31 March 2020

1 reference

Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis

31 March 2020

1 reference

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

31 March 2020

1 reference

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

31 March 2020

1 reference

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

31 March 2020

1 reference

15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit

31 March 2020

1 reference

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

31 March 2020

1 reference

NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosisin Vitro

31 March 2020

1 reference

Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins

31 March 2020

1 reference

Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).

31 March 2020

1 reference

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI915

1 reference

5 August 2017

1 reference